Clinical Trial Update: Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement [Phase 4]

View source ↗

Summary

A phase 4 multicenter study evaluating the long-term performance of the DePuy ASR hip system in resurfacing and primary total hip replacement has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Collagen Disorders
• Congenital Hip Dysplasia
• Nonunion of Femoral Fractures
• Osteoarthritis
• Osteonecrosis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Slipped Capital Femoral Epiphysis

Drugs mentioned

• ASR Hip System

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED